Pharmacoeconomics of mobilization
Highlights from EHA 2016 press briefings: POLLUX and EURO-SKI trials and BiTE antibodies
Nivolumab in combination with azacytidine in patients with relapsed acute myeloid leukemia (AML)
Naval G. Daver
Graft versus host disease: how to treat it?
Updated analysis of Phase III trial of idelalisib combined with bendamustine and rituximab in CLL